Dr. Sarah Camille Glover, DO

Dr. Glover practices at University Medical Center New Orleans in New Orleans, Louisiana, part of LCMC Health.

Dr. Glover's NPI, 1174637300, was assigned on August 17, 2006. Dr. Glover graduated from Midwestern University, Chicago College of Osteopathic Med in 1998. Dr. Glover holds Louisiana license 335831.

Dr. Glover's primary practice is University Medical Center New Orleans, at 2000 Canal Street, New Orleans, LA 70112 in Orleans Parish. The practice phone is (504) 702-3000.

Dr. Glover's primary practice is University Medical Center New Orleans in New Orleans, Louisiana, part of LCMC Health. Dr. Glover is also affiliated with East Jefferson General Hospital. The medical group on file is Tulane Doctors. Dmand AI also links Dr. Glover to 1 more hospital and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Glover practices, 3 sites in all. Vendor and product names are available with a free account.

Gastroenterology is Dr. Glover's primary specialty in the NPI Registry, under taxonomy code 207RG0100X. Dr. Glover is board certified in gastroenterology by the American Board of Internal Medicine. Dmand AI has Dr. Glover's licenses on file in 3 states: Louisiana, Illinois and Mississippi.

CMS data shows 221 Medicare services from Dr. Glover across 6 procedure codes in 2024, for 114 Medicare patients. Medicare paid $15,670 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 114 Medicare patients who saw Dr. Glover in 2024. The largest group is under 65, with 46 patients. 75% of them have high blood pressure, and 63% have high cholesterol. 40% are also on Medicaid. Their average risk score is 1.87, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Glover's median patient age at 53, with 65% women.

In 2024, Dr. Glover wrote 740 Medicare Part D claims for 136 patients. 60% of them were for generic drugs. CMS names the drug for 511 of them, across 20 drugs with 11 or more claims each, at $2,974,655 in total drug cost. In 2023, CMS named 1,713 claims across 39 drugs.

Dr. Glover accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Glover as offering telehealth. CMS counts 21 procedures of colonoscopy by Dr. Glover, more than 48% of the clinicians it reports for that procedure.

Dmand AI links 73 papers to Dr. Glover, published from 2011 to 2025. 2021 was the busiest year, with 9. The most frequent topics are Inflammatory Bowel Diseases, COVID-19 and Mastocytosis. Dr. Glover has published most often in Inflamm Bowel Dis. Dr. Glover's most frequent co-authors are Jonathan Joseph Lyons, MD, Bruce H. Horwitz, MD, PhD and Adam M. Parker, MD.

Dmand AI links Dr. Glover to 5 clinical trials. 1 is still active or recruiting. Conditions studied include Colitis, Ulcerative, Colitis and Crohn Disease. Eli Lilly and Company sponsors the most, 3.

CMS Open Payments shows 620 general payments to Dr. Glover from 41 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 56% of the total. Janssen Research & Development, LLC paid the most, $169,043. It also lists 8 research payments totaling $1,156 from 2016 to 2019.

Dr. Glover graduated from Midwestern University, Chicago College of Osteopathic Med in 1998.